{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:33:19Z","timestamp":1769823199069,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00105-025-05491-3","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:26:22Z","timestamp":1741685182000},"page":"231-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kutane Manifestationen der Sarkoidose","Cutaneous manifestations of sarcoidosis"],"prefix":"10.1007","volume":"76","author":[{"given":"Henning","family":"Klapproth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Kubacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Fabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"von Stebut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"5491_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2040622318790197","volume":"9","author":"EV Arkema","year":"2018","unstructured":"Arkema\u00a0EV, Cozier\u00a0YC (2018) Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 9:227\u2013240","journal-title":"Ther Adv Chronic Dis"},{"key":"5491_CR2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/jdv.13760","volume":"30","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert\u00a0P, Wetter\u00a0DA, Crowson\u00a0CS, Matteson\u00a0EL (2016) Epidemiology of cutaneous sarcoidosis, 1976\u20132013: a\u00a0population-based study from Olmsted County, Minnesota. J\u00a0Eur Acad Dermatol Venereol 30:1799\u20131804","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5491_CR3","unstructured":"Prystowsky S, Sanchez M Cutaneous Sarcoidosis: Management. UpToDate. In: Ofori AO (Hrsg) Wolters Kluwer,"},{"key":"5491_CR4","doi-asserted-by":"crossref","first-page":"106688","DOI":"10.1016\/j.rmed.2021.106688","volume":"191","author":"A Lundkvist","year":"2022","unstructured":"Lundkvist\u00a0A, Kullberg\u00a0S, Arkema\u00a0EV, Cedelund\u00a0K, Eklund\u00a0A, Grunewald\u00a0J et\u00a0al (2022) Differences in disease presentation between men and women with sarcoidosis: A\u00a0cohort study. Respir Med 191:106688","journal-title":"Respir Med"},{"key":"5491_CR5","first-page":"231","volume":"20","author":"R Cimaz","year":"2002","unstructured":"Cimaz\u00a0R, Ansell\u00a0BM (2002) Sarcoidosis in the pediatric age. Clin Exp Rheumatol 20:231\u2013237","journal-title":"Clin Exp Rheumatol"},{"key":"5491_CR6","first-page":"2153","volume-title":"Sarcoidosis","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi\u00a0MC (2007) Sarcoidosis, S\u00a02153\u20132165"},{"key":"5491_CR7","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fimmu.2020.01719","volume":"11","author":"LW Locke","year":"2020","unstructured":"Locke\u00a0LW, Schlesinger\u00a0LS, Crouser\u00a0ED (2020) Current Sarcoidosis Models and the Importance of Focusing on the Granuloma. Front Immunol 11:1719","journal-title":"Front Immunol"},{"key":"5491_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-30615-x","volume":"13","author":"W Damsky","year":"2022","unstructured":"Damsky\u00a0W, Wang\u00a0A, Kim\u00a0DJ, Young\u00a0BD, Singh\u00a0K, Murphy\u00a0MJ et\u00a0al (2022) Inhibition of type\u00a01 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nat Commun 13:1\u201317","journal-title":"Nat Commun"},{"key":"5491_CR9","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","volume":"379","author":"W Damsky","year":"2018","unstructured":"Damsky\u00a0W, Thakral\u00a0D, Emeagwali\u00a0N, Galan\u00a0A, King\u00a0B (2018) Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis. N\u00a0Engl J Med 379:2540\u20132546","journal-title":"N Engl J Med"},{"key":"5491_CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-3083.2009.03517.x","volume":"24","author":"MM Ali","year":"2010","unstructured":"Ali\u00a0MM, Atwan\u00a0AA, Gonzalez\u00a0ML (2010) Cutaneous sarcoidosis: Updates in the pathogenesis. J\u00a0Eur Acad Dermatol Venereol 24:747\u2013755","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5491_CR11","doi-asserted-by":"crossref","unstructured":"Chioma OS, Wiggins ZD, Rea S, Drake WP (2024) Infectious and non-infectious precipitants of sarcoidosis. J\u00a0Autoimmun 103239:","DOI":"10.1016\/j.jaut.2024.103239"},{"key":"5491_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.rmed.2017.06.004","volume":"132","author":"MP Webber","year":"2017","unstructured":"Webber\u00a0MP, Yip\u00a0J, Zeig-Owens\u00a0R, Moir\u00a0W, Ungprasert\u00a0P, Crowson\u00a0CS et\u00a0al (2017) Post-9\/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers. Respir Med 132:232\u2013237","journal-title":"Respir Med"},{"key":"5491_CR13","doi-asserted-by":"crossref","unstructured":"Sipahi Demirkok S, Basaranoglu M, Dervis E, Bal M, Karayel T (2006) Analysis of 87\u00a0patients with L\u00f6fgren\u2019s syndrome and the pattern of seasonality of subacute sarcoidosis. 11:456\u2013461","DOI":"10.1111\/j.1440-1843.2006.00874.x"},{"key":"5491_CR14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCP.0000000000000800","volume":"27","author":"J Miedema","year":"2021","unstructured":"Miedema\u00a0J, Nunes\u00a0H (2021) Drug-induced sarcoidosis-like reactions. Curr Opin Pulm Med 27:439\u2013447","journal-title":"Curr Opin Pulm Med"},{"key":"5491_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2230.2011.04128.x","volume":"36","author":"J Marcoval","year":"2011","unstructured":"Marcoval\u00a0J, Ma\u00f1\u00e1\u00a0J, Rubio\u00a0M (2011) Specific cutaneous lesions in patients with systemic sarcoidosis: Relationship to severity and chronicity of disease. Clin Exp Dermatol 36:739\u2013744","journal-title":"Clin Exp Dermatol"},{"key":"5491_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40257-014-0079-3","volume":"15","author":"KA Wanat","year":"2014","unstructured":"Wanat\u00a0KA, Rosenbach\u00a0M (2014) A\u00a0practical approach to cutaneous sarcoidosis. Am J Clin Dermatol 15:283\u2013297","journal-title":"Am J Clin Dermatol"},{"key":"5491_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.det.2023.02.012","volume":"41","author":"N Ezeh","year":"2023","unstructured":"Ezeh\u00a0N, Caplan\u00a0A, Rosenbach\u00a0M (2023) Cutaneous sarcoidosis. Dermatol Clin 41:455\u2013470","journal-title":"Dermatol Clin"},{"key":"5491_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00105-015-3646-5","volume":"66","author":"B Weidenthaler-Barth","year":"2015","unstructured":"Weidenthaler-Barth\u00a0B, Steinbrink\u00a0K, K\u00fcmmel\u00a0A et\u00a0al (2015) Sarkoidose. Hautarzt 66:549\u2013563. https:\/\/doi.org\/10.1007\/s00105-015-3646-5","journal-title":"Hautarzt"},{"key":"5491_CR19","unstructured":"Altmeyer P, Bacharach-Buhles M Dermatologie, Venerologie, Allergologie, Umweltmedizin (Online). Springer, Berlin"},{"key":"5491_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clindermatol.2007.03.007","volume":"25","author":"RM Marchell","year":"2007","unstructured":"Marchell\u00a0RM, Judson\u00a0MA (2007) Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 25:295\u2013302","journal-title":"Clin Dermatol"},{"key":"5491_CR21","first-page":"727","volume-title":"Granulomat\u00f6se Erkrankungen","author":"M Mempel","year":"2018","unstructured":"Mempel\u00a0M (2018) Granulomat\u00f6se Erkrankungen, S\u00a0727\u2013744"},{"key":"5491_CR22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6","volume":"43","author":"C Garc\u00eda-Porr\u00faa","year":"2000","unstructured":"Garc\u00eda-Porr\u00faa\u00a0C, Gonz\u00e1lez-Gay\u00a0MA, V\u00e1zquez-Caruncho\u00a0M, L\u00f3pez-Lazaro\u00a0L, Lueiro\u00a0M, Fern\u00e1ndez\u00a0ML et\u00a0al (2000) Erythema nodosum: Etiologic and predictive factors in a\u00a0defined population. Arthritis Rheum 43:584\u2013592","journal-title":"Arthritis Rheum"},{"key":"5491_CR23","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser\u00a0ED, Maier\u00a0LA, Baughman\u00a0RP, Abston\u00a0E, Bernstein\u00a0RC, Blankstein\u00a0R et\u00a0al (2020) Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 201:E26\u2013E51","journal-title":"Am J Respir Crit Care Med"},{"key":"5491_CR24","doi-asserted-by":"crossref","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S et\u00a0al (2021) Sarcoidosis: A\u00a0clinical overview from symptoms to diagnosis. 10:","DOI":"10.3390\/cells10040766"},{"key":"5491_CR25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0303-6987.2004.00157.x","volume":"31","author":"NJ Ball","year":"2004","unstructured":"Ball\u00a0NJ, Kho\u00a0GT, Martinka\u00a0M (2004) The histologic spectrum of cutaneous sarcoidosis: A\u00a0study of twenty-eight cases. J\u00a0Cutan Pathol 31:160\u2013168","journal-title":"J Cutan Pathol"},{"key":"5491_CR26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1468-3083.2009.03153.x","volume":"23","author":"JC Cardoso","year":"2009","unstructured":"Cardoso\u00a0JC, Cravo\u00a0M, Reis\u00a0JP, Tellechea\u00a0O (2009) Cutaneous sarcoidosis: A\u00a0histopathological study. J\u00a0Eur Acad Dermatology Venereol 23:678\u2013682","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"5491_CR27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0560.2006.00563.x","volume":"33","author":"C Mangas","year":"2006","unstructured":"Mangas\u00a0C, Fern\u00e1ndez-Figueras\u00a0MT, Fit\u00e9\u00a0E, Fern\u00e1ndez-Chico\u00a0N, S\u00e0bat\u00a0M, Ferr\u00e1ndiz\u00a0C (2006) Clinical spectrum and histological analysis of 32\u00a0cases of specific cutaneous sarcoidosis. J\u00a0Cutan Pathol 33:772\u2013777","journal-title":"J Cutan Pathol"},{"key":"5491_CR28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5858\/arpa.2014-0051-RA","volume":"139","author":"Y Rosen","year":"2015","unstructured":"Rosen\u00a0Y (2015) Four decades of necrotizing sarcoid granulomatosis what do we know now? Arch Pathol Lab Med 139:252\u2013262","journal-title":"Arch Pathol Lab Med"},{"key":"5491_CR29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"American Thoracic Society","year":"1999","unstructured":"American Thoracic Society (1999) Statement on Sarcoidosis; ATS\/ERS\/WASGOG. Am J Respir Crit Care Med 160:736\u2013755","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5491_CR30","doi-asserted-by":"crossref","unstructured":"Harper LJ, Farver CF, Yadav R, Culver DA (2024) A\u00a0framework for exclusion of alternative diagnoses in sarcoidosis. J\u00a0Autoimmun 103288:","DOI":"10.1016\/j.jaut.2024.103288"},{"key":"5491_CR31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre\u00a0D, Prasse\u00a0A, Nunes\u00a0H, Uzunhan\u00a0Y, Brillet\u00a0PY, M\u00fcller-Quernheim\u00a0J (2014) Sarcoidosis. Lancet 383:1155\u20131167","journal-title":"Lancet"},{"key":"5491_CR32","doi-asserted-by":"crossref","unstructured":"Gwadera \u0141, Bia\u0142as AJ, Kumor-Kisielewska A, Mi\u0142kowska-Dymanowska J, Majewski S, Piotrowski WJ (2023) Calcium, Phosphate, and Vitamin\u00a0D Status in Patients with Sarcoidosis\u2014Associations with Disease Activity and Symptoms. J\u00a0Clin Med 12:","DOI":"10.3390\/jcm12144745"},{"key":"5491_CR33","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/ijd.16547","volume":"62","author":"CJ Evenson","year":"2023","unstructured":"Evenson\u00a0CJ, Rosenbach\u00a0M, Shields\u00a0BE (2023) Utility of angiotensin-converting enzyme and serum calcium levels in cutaneous sarcoidosis. Int J Dermatol 62:910\u2013914","journal-title":"Int J Dermatol"},{"key":"5491_CR34","first-page":"1","volume":"14","author":"LEM Eurelings","year":"2019","unstructured":"Eurelings\u00a0LEM, Miedema\u00a0JR, Dalm\u00a0VASH, Van Daele\u00a0PLA, Van Hagen\u00a0PM, Van Laar\u00a0JAM et\u00a0al (2019) Sensitivity and specificity of serum soluble interleukin\u20112 receptor for diagnosing sarcoidosis in a\u00a0population of patients suspected of sarcoidosis. PLoS ONE 14:1\u201315","journal-title":"PLoS ONE"},{"key":"5491_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-022-02308-y","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou\u00a0Y, Chen\u00a0X, Zhao\u00a0M, Lower\u00a0EE, Baughman\u00a0RP (2023) SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis. Respir Res 24:1\u20139","journal-title":"Respir Res"},{"key":"5491_CR36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17476348.2020.1751614","volume":"14","author":"MC Schimmelpennink","year":"2020","unstructured":"Schimmelpennink\u00a0MC, Quanjel\u00a0M, Vorselaars\u00a0ADM, Wiertz\u00a0I, Veltkamp\u00a0M, Van Moorsel\u00a0CHM et\u00a0al (2020) Value of serum soluble interleukin\u20112 receptor as a\u00a0diagnostic and predictive biomarker in sarcoidosis. Expert Rev Respir Med 14:749\u2013756","journal-title":"Expert Rev Respir Med"},{"key":"5491_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01443","volume":"11","author":"R Kraaijvanger","year":"2020","unstructured":"Kraaijvanger\u00a0R, Janssen Bon\u00e1s\u00a0M, Vorselaars\u00a0ADM, Veltkamp\u00a0M (2020) Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol 11:1\u201317","journal-title":"Front Immunol"},{"key":"5491_CR38","first-page":"525","volume":"52","author":"E Neville","year":"1983","unstructured":"Neville\u00a0E, Walker\u00a0AN, James\u00a0GD (1983) Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients. Q\u00a0J Med 52:525\u2013533","journal-title":"Q J Med"},{"key":"5491_CR39","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent\u00a0M, Crouser\u00a0ED, Grunewald\u00a0J (2021) Challenges of Sarcoidosis and Its Management. N\u00a0Engl J Med 385:1018\u20131032","journal-title":"N Engl J Med"},{"key":"5491_CR40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2165\/00003495-200868100-00003","volume":"68","author":"CB Doherty","year":"2008","unstructured":"Doherty\u00a0CB, Rosen\u00a0T (2008) Evidence-based therapy for cutaneous sarcoidosis. Drugs 68:1361\u20131383","journal-title":"Drugs"},{"key":"5491_CR41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2133.2002.04727.x","volume":"147","author":"N Katoh","year":"2002","unstructured":"Katoh\u00a0N, Mihara\u00a0H, Yasuno\u00a0H (2002) Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 147:154\u2013156","journal-title":"Br J Dermatol"},{"key":"5491_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdcr.2023.05.032","volume":"38","author":"JS Smith","year":"2023","unstructured":"Smith\u00a0JS, Woodbury\u00a0MJ, Merola\u00a0JF (2023) Ruxolitinib cream for the treatment of cutaneous sarcoidosis. JAAD Case Rep 38:111\u2013112","journal-title":"JAAD Case Rep"},{"key":"5491_CR43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.020","volume":"108","author":"R Fern\u00e1ndez-Ram\u00f3n","year":"2023","unstructured":"Fern\u00e1ndez-Ram\u00f3n\u00a0R, Gait\u00e1n-Valdiz\u00e1n\u00a0JJ, Gonz\u00e1lez-Maz\u00f3n\u00a0I, S\u00e1nchez-Bilbao\u00a0L, Mart\u00edn-Varillas\u00a0JL, Mart\u00ednez-L\u00f3pez\u00a0D et\u00a0al (2023) Systemic treatment in sarcoidosis: Experience over two decades. Eur J Intern Med 108:60\u201367","journal-title":"Eur J Intern Med"},{"key":"5491_CR44","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.xjidi.2023.100220","volume":"3","author":"E Hwang","year":"2023","unstructured":"Hwang\u00a0E, Abdelghaffar\u00a0M, Shields\u00a0BE, Damsky\u00a0W (2023) Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A\u00a0Review of the Evidence and Implications for Understanding Disease Pathogenesis. JID Innov 3:100220","journal-title":"JID Innov"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05491-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:59:46Z","timestamp":1743267586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05491-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5491"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05491-3","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"17 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"E.\u00a0von Stebut: A.\u00a0Finanzielle Interessen: E.\u00a0von Stebut gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Chef\u00e4rztin\/Klinikdirektorin, Klinik f\u00fcr Dermatologie und Venerologie K\u00f6ln, Kerpener Str.\u00a062, 50935 K\u00f6ln | Mitgliedschaften: Deutsche Dermatologische Gesellschaft | Pr\u00e4sident:in: International Society for Tropical Dermatoloy. H. Klapproth: A.\u00a0Finanzielle Interessen: Kostenerstattung bei passiver Teilnahme; Galderma.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Assistenzarzt, Institut f\u00fcr Klinik f\u00fcr Dermatologie und Venerologie, Uniklinik K\u00f6ln | Mitgliedschaft: DDG. M.\u00a0Fabri: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: DFG, VolkswagenStiftung. \u2013\u00a0Honorar\/Kostenerstattung: Derma Update (medupdate), Consilium (Infektopharm), FoMF, RG \u00c4rztefortbildungen und weitere von (Uni\u2011)Kliniken, Fachgesellschaften oder Berufsverb\u00e4nden organisierte Fortbildungen.\u00a0\u2013 Advisory Board: LEO Pharma. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Leitender Oberarzt, Klinik f\u00fcr Dermatologie, Uniklinik K\u00f6ln | Mitgliedschaften in Fachgesellschaften: Deutsche Dermatologische Gesellschaft, European Society for Dermatological Research, Arbeitsgemeinschaft Dermatologische Forschung, Arbeitsgemeinschaft f\u00fcr Dermatologische Infektiologie und Tropendermatologie, Deutsche STI Gesellschaft, Kommission Antiinfektiva, Resistenz und Therapie am Robert Koch-Institut. T.\u00a0Kubacki: A.\u00a0Finanzielle Interessen: T.\u00a0Kubacki gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Facharzt f\u00fcr Innere Medizin und Nephrologie und Innere Medizin und Rheumatologie, Uniklinik K\u00f6ln | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Rheumatologie, European Vasculitis Society (EUVAS).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}